Extraarticular manifestations of rheumatoid arthritis develop in patients receiving anti-tumor necrosis factor-α treatment: a retrospective chart review from a UK center.

Objective: To assess the evolution of preexisting extraarticular manifestations of rheumatoid arthritis (EA-RA) in patients treated with anti-tumor necrosis factor-α (TNF-α), as well as the development of new EA-RA.

Methods: We assessed EA-RA in 152 patients receiving anti-TNF-α treatment.

Results: In 22 cases, a new EA-RA developed.